RT Book, Section
A1 Lee, Fred
A1 Groth, Shawn S.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Burt, Bryan M.
A2 Groth, Shawn S.
A2 Loor, Gabriel
A2 Wolf, Andrea S.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1170416659
T1 Overview of Robotics in Thoracic Surgery
T2 Sugarbaker’s Adult Chest Surgery, 3e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260026931
LK accesssurgery.mhmedical.com/content.aspx?aid=1170416659
RD 2024/04/20
AB Adding  to  the  ever-growing  armamentarium  of  minimally  invasive  surgical  technology,  robotic  devices  were  first  introduced  in  1985  when  an  industrial  robotic  arm  was  modified  to  perform  a  stereotactic  brain  biopsy.1  With  the  only  U.S.  Food  and  Drug  Administration  (FDA)-approved  surgical  system  currently  on  the  market,  Intuitive  Surgical  Inc.  (Sunnyvale,  CA)  launched  the  da  Vinci  Surgical  System  in  1999  and  it  was  cleared  by  the  FDA  for  laparoscopic  surgery  in  2000.2  Although  Intuitive’s  initial  market  efforts  were  directed  toward  minimally  invasive  cardiac  surgery,  its  applications  have  expanded,  initially  toward  urologic  and  gynecologic  surgery  and  now  toward  the  full  gamut  of  laparoscopic  and  thoracoscopic  procedures.  The  robotic  platform  is  an  alternative  approach  for  all  operations  performed  by  standard  thoracoscopy  and  laparoscopy.  Lobectomy3  (including  3-arm4  and  4-arm  approaches5),  chest  wall  resection  with  robotic  assistance  for  the  parenchymal  dissection,  removal  of  mediastinal  masses  (including  thymectomy),6  diaphragm  plication,7  anti-reflux  procedures,8  and  minimally  invasive  esophagectomy9,10  have  all  been  described  in  the  thoracic  robotic  surgical  literature.11